EverSource Wealth Advisors’s scPharmaceuticals SCPH Stock Holding History

EverSource Wealth Advisors’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-63	Closed	-$357	–	4417
2025 Q3	$357	Buy	63 +4	+7%	+$20	﹤0.01%	4023
2025 Q2	$225	Sell	59 -33	-36%	-$102	﹤0.01%	4043
2025 Q1	$242	Buy	92 +46	+100%	+$150	﹤0.01%	3661
2024 Q4	$163	Buy	+46	New	+$176	﹤0.01%	3472

EverSource Wealth Advisors's SCPH Position: Q4 2025 in Review

EverSource Wealth Advisors sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 63 shares — an estimated $357 sold.

EverSource Wealth Advisors first reported a position in SCPH in Q4 2024 and held it in 4 quarters. The position peaked at $357 in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

EverSource Wealth Advisors reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
EverSource Wealth Advisors sold 63 scPharmaceuticals shares in Q4 2025, an estimated $357.
EverSource Wealth Advisors first reported a position in scPharmaceuticals in Q4 2024 and held it in 4 quarters.
EverSource Wealth Advisors's scPharmaceuticals position peaked at $357 in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.